The coronavirus exposed US reliance on India for generic drugs. That supply chain all hinges on China

India gets around 68% of its raw materials — known as active pharmaceutical ingredients (APIs) — from China. Any disruption in that supply chain can create a major problem, especially during a …
( read original story …)